Latest Blog Posts Tagged "Parkinson's Progression Markers Initiative"
June 23, 2017
Researchers have developed a tool to predict cognitive decline in PD for use in designing clinical studies. The team analyzed data from multiple studies including PPMI.
June 02, 2017
Sue Lifschiz of Santa Rosa, California was diagnosed with PD in 2002. She joined PPMI to find a biomarker for earlier diagnosis and better disease tracking.
May 17, 2017
Analysis of data from the MJFF-sponsored Parkinson's Progression Markers Initiative gives window into how and why cognitive problems develop in PD
April 18, 2017
A recent study using data from PPMI has identified risk factors that may predict the development of early psychosis in Parkinson's.
February 14, 2017
A new study suggests that evaluating levels of a certain protein in the blood may help distinguish Parkinson's from certain atypical parkinsonisms.
February 14, 2017
This study is a major step for PD research as it is the first drug trial where one's genetic information determines eligibility and is testing a potential therapy to slow or stop disease progression.
February 06, 2017
Barbara and Jay Robinson discuss their decision to participate in Parkinson's genetics research.
November 29, 2016
Tools developed by the winners from UC San Francisco and Weill Cornell Medicine could accelerate testing of new Parkinson's treatments by helping researchers design trials and choose study volunteers.
November 22, 2016
For Jessica O'Brien, Facebook was a place to post pictures of her dogs, until it became a starting point in her journey to understand Parkinson's disease.
October 11, 2016
In this podcast, MJFF staff scientist Marco Baptista, PhD, discusses the genetics and biology of LRRK2 and the role of the Foundation in advancing development of LRRK2 therapeutics.